Capacity Bio

Biotechnology
$19.2Mlatest round · Venture round · Dec 2022 · 3 yr ago
1backers · Insight Partners
50+team · employees, estimated range
2021founded

Overview

Capacity Bio is a private, biotech company developing a first-in-class mitophagy therapeutic platform, along with the most advanced analytical toolkit to characterize mitochondria.

Funding and backers

Total raised
$19.2M
1 round on record
Latest round
$19.2M
Venture round · Dec 2022 · 3 yr ago
Team
51-200
employees, estimated range
Backers
1
Insight Partners
The money's age
Long since its last round
46 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Dec 21, 2022 Raised a round Venture round $19.2M · SEC Form D 2021 Founded
Funding rounds
RoundDateAmountInvestorsSource
Venture round Dec 2022 $19.2M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity Capacity Bio, Inc. SEC Form D
Founders and leadersfrom filings, registers and the company's site
Kenneth HorneExecutive Officer, DirectorSEC Form D
Amy WangExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Insight Partners fund
Investors in similar startupsfunds that back the companies most like this one
Y Combinator
backs Ultralight
Techstars
backs Miphic
High-Tech Gründerfonds
backs Hprobe
The Creator Fund
backs Miphic
VU Venture Partners
backs LIFELENZ
Source Code Capital
backs Starnatx
Similar startupsby what they do, their industry and backers
Algenex
Algenex is a private biotech company with proprietary and patented technologies to boost the production of recombinant proteins using BVES…
LIFELENZSeries B $32M · 4 yr ago
Workforce Management Platform built for your business, loved byyour employees .. Save more, win more. LIFELENZ helps customers achieve an…
Ultralight
Ultralight. Ultralight is a GPU-accelerated toolkit to embed modern HTML in games and native apps.
Miphic
Miphic. Therapeutic targeting of mitochondria has a great potential in:.
Hprobe
Hprobe wafer-level tester hasten development and production of magnetic devices with its full features to characterize, control and monitor…
EnterobiotixVenture round · 7 mo ago · Founded 2017 · 51-200 employees
EnteroBiotix is a clinical-stage biopharmaceutical company developing best-in-class full-spectrum microbial therapeutics.

Financials

Total raised
$19.2M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
Round Announced Amount
Venture - Series Unknown 2022 $19.2M Details

People

Kenneth Horne
Executive Officer, Director
SEC Form D
Amy Wang
Executive Officer, Director
SEC Form D
Cristina Ghenoiu
Director
SEC Form D
Dylan Morris
Director
SEC Form D
Taro Inaba
Director
SEC Form D
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors1
Insight PartnersVia a fund
812 portfolio companies
Report a mistake

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Palo Alto United States
HQ
50-200 est. staff